367 related articles for article (PubMed ID: 19137007)
1. Role of miR-143 targeting KRAS in colorectal tumorigenesis.
Chen X; Guo X; Zhang H; Xiang Y; Chen J; Yin Y; Cai X; Wang K; Wang G; Ba Y; Zhu L; Wang J; Yang R; Zhang Y; Ren Z; Zen K; Zhang J; Zhang CY
Oncogene; 2009 Mar; 28(10):1385-92. PubMed ID: 19137007
[TBL] [Abstract][Full Text] [Related]
2. The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS.
Zhao WG; Yu SN; Lu ZH; Ma YH; Gu YM; Chen J
Carcinogenesis; 2010 Oct; 31(10):1726-33. PubMed ID: 20675343
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-224 is associated with colorectal cancer progression and response to 5-fluorouracil-based chemotherapy by KRAS-dependent and -independent mechanisms.
Amankwatia EB; Chakravarty P; Carey FA; Weidlich S; Steele RJ; Munro AJ; Wolf CR; Smith G
Br J Cancer; 2015 Apr; 112(9):1480-90. PubMed ID: 25919696
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA profiling differentiates colorectal cancer according to KRAS status.
Mosakhani N; Sarhadi VK; Borze I; Karjalainen-Lindsberg ML; Sundström J; Ristamäki R; Osterlund P; Knuutila S
Genes Chromosomes Cancer; 2012 Jan; 51(1):1-9. PubMed ID: 21922590
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-31 activates the RAS pathway and functions as an oncogenic MicroRNA in human colorectal cancer by repressing RAS p21 GTPase activating protein 1 (RASA1).
Sun D; Yu F; Ma Y; Zhao R; Chen X; Zhu J; Zhang CY; Chen J; Zhang J
J Biol Chem; 2013 Mar; 288(13):9508-18. PubMed ID: 23322774
[TBL] [Abstract][Full Text] [Related]
6. KRAS up-regulates the expression of miR-181a, miR-200c and miR-210 in a three-dimensional-specific manner in DLD-1 colorectal cancer cells.
Ota T; Doi K; Fujimoto T; Tanaka Y; Ogawa M; Matsuzaki H; Kuroki M; Miyamoto S; Shirasawa S; Tsunoda T
Anticancer Res; 2012 Jun; 32(6):2271-5. PubMed ID: 22641662
[TBL] [Abstract][Full Text] [Related]
7. Deregulated miRNAs in hereditary breast cancer revealed a role for miR-30c in regulating KRAS oncogene.
Tanic M; Yanowsky K; Rodriguez-Antona C; Andrés R; Márquez-Rodas I; Osorio A; Benitez J; Martinez-Delgado B
PLoS One; 2012; 7(6):e38847. PubMed ID: 22701724
[TBL] [Abstract][Full Text] [Related]
8. miR-200c inhibits breast cancer proliferation by targeting KRAS.
Song C; Liu LZ; Pei XQ; Liu X; Yang L; Ye F; Xie X; Chen J; Tang H; Xie X
Oncotarget; 2015 Oct; 6(33):34968-78. PubMed ID: 26392416
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic KRAS regulates miR-200c and miR-221/222 in a 3D-specific manner in colorectal cancer cells.
Tsunoda T; Takashima Y; Yoshida Y; Doi K; Tanaka Y; Fujimoto T; Machida T; Ota T; Koyanagi M; Kuroki M; Sasazuki T; Shirasawa S
Anticancer Res; 2011 Jul; 31(7):2453-9. PubMed ID: 21873159
[TBL] [Abstract][Full Text] [Related]
10. Selective targeting of KRAS-mutant cells by miR-126 through repression of multiple genes essential for the survival of KRAS-mutant cells.
Hara T; Jones MF; Subramanian M; Li XL; Ou O; Zhu Y; Yang Y; Wakefield LM; Hussain SP; Gaedcke J; Ried T; Luo J; Caplen NJ; Lal A
Oncotarget; 2014 Sep; 5(17):7635-50. PubMed ID: 25245095
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-622 functions as a tumor suppressor by targeting K-Ras and enhancing the anticarcinogenic effect of resveratrol.
Han Z; Yang Q; Liu B; Wu J; Li Y; Yang C; Jiang Y
Carcinogenesis; 2012 Jan; 33(1):131-9. PubMed ID: 22016468
[TBL] [Abstract][Full Text] [Related]
12. Involvement of epigenetically silenced microRNA-181c in gastric carcinogenesis.
Hashimoto Y; Akiyama Y; Otsubo T; Shimada S; Yuasa Y
Carcinogenesis; 2010 May; 31(5):777-84. PubMed ID: 20080834
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer.
Tang JT; Wang JL; Du W; Hong J; Zhao SL; Wang YC; Xiong H; Chen HM; Fang JY
Carcinogenesis; 2011 Aug; 32(8):1207-15. PubMed ID: 21665895
[TBL] [Abstract][Full Text] [Related]
14. miRNA expression profiling of lung adenocarcinomas: correlation with mutational status.
Dacic S; Kelly L; Shuai Y; Nikiforova MN
Mod Pathol; 2010 Dec; 23(12):1577-82. PubMed ID: 20818338
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA.
Wang Y; Tang Q; Li M; Jiang S; Wang X
Biochem Biophys Res Commun; 2014 Feb; 444(2):199-204. PubMed ID: 24440701
[TBL] [Abstract][Full Text] [Related]
16. microRNA-202-3p inhibits cell proliferation by targeting ADP-ribosylation factor-like 5A in human colorectal carcinoma.
Wang Q; Huang Z; Guo W; Ni S; Xiao X; Wang L; Huang D; Tan C; Xu Q; Zha R; Zhang J; Sheng W; He X; Du X
Clin Cancer Res; 2014 Mar; 20(5):1146-57. PubMed ID: 24327274
[TBL] [Abstract][Full Text] [Related]
17. MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2.
Ding L; Xu Y; Zhang W; Deng Y; Si M; Du Y; Yao H; Liu X; Ke Y; Si J; Zhou T
Cell Res; 2010 Jul; 20(7):784-93. PubMed ID: 20548334
[TBL] [Abstract][Full Text] [Related]
18. Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signalling pathway in advanced colorectal cancer.
Seth R; Crook S; Ibrahem S; Fadhil W; Jackson D; Ilyas M
Gut; 2009 Sep; 58(9):1234-41. PubMed ID: 19474002
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes.
Schepeler T; Holm A; Halvey P; Nordentoft I; Lamy P; Riising EM; Christensen LL; Thorsen K; Liebler DC; Helin K; Ørntoft TF; Andersen CL
Oncogene; 2012 May; 31(22):2750-60. PubMed ID: 21963845
[TBL] [Abstract][Full Text] [Related]
20. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
